Sun Pharma gets USFDA nod for generic diabetes tablets
Quotes

Sun Pharma gets USFDA nod for generic diabetes tablets

Last Updated: Friday, July 12, 2013, 14:44
 
 Comment 0
 
Sun Pharma gets USFDA nod for generic diabetes tablets
New Delhi: Drug firm Sun Pharmaceutical Industries today said it has received final approval from the US health regulator for its generic Repaglinide tablets used for treatment of diabetes.

The company is eligible for a 180-day marketing exclusivity in the US as its subsidiary is the first-to-file an abbreviated new drug applications (ANDA) for the product with a para IV certification, it added.

United States Food and Drug Administration (USFDA) has granted final approval to company's subsidiary for its ANDA for generic version of Repaglinide tablets in the strengths of 1 mg and 2 mg, Sun Pharma said in a statement.

The company's tablets in both the strengths are generic versions of Novo Nordisk's Prandin tablets, it added.

"These tablets have annual sales of approximately USD 200 million in the US. Repaglinide tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type-2 diabetes mellitus," Sun Pharma said.

Shares of Sun Pharmaceutical Industries were today trading at Rs 1,091.85 per scrip in the morning trade on BSE, down 0.30 percent from its previous close.

PTI



First Published: Friday, July 12, 2013, 14:43


Comments


comments powered by Disqus
World`s Top 10 Powerful Women
World`s Top 10 Powerful Women
New Age XUV500
New Age XUV500
Renault Kwid
Renault Kwid
Tata GenX Nano
Tata GenX Nano
2015 Indian Roadmaster
2015 Indian Roadmaster

Web Wrap
Contact Us : Privacy Policy : Legal Disclaimer
Copyright © Zee Media Corporation Ltd. All rights reserved